Home Signal Transduction from Bradykinin, Angiotensin, Adrenergic and Muscarinic Receptors to Effector Enzymes, Including ADP-Ribosyl Cyclase
Article
Licensed
Unlicensed Requires Authentication

Signal Transduction from Bradykinin, Angiotensin, Adrenergic and Muscarinic Receptors to Effector Enzymes, Including ADP-Ribosyl Cyclase

  • Haruhiro Higashida , Shigeru Yokoyama , Naoto Hoshi , Minako Hashii , Alla Egorova , Zhen-Guo Zhong , Mami Noda , Mohammad Shahidullah , Megumi Taketo , Rimma Knijnik , Yasuhiro Kimura , Hiroto Takahashi , Xiao-Liang Chen , Yeonsook Shin and Jia-Sheng Zhang
Published/Copyright: July 5, 2005
Biological Chemistry
From the journal Volume 382 Issue 1

Abstract

Muscarinic acetylcholine receptors in NG108-15 neuroblastoma x glioma cells, and ?-adrenergic or angiotensin II receptors in cortical astrocytes and/or ventricular myocytes, utilize the direct signaling pathway to ADP-ribosyl cyclase within cell membranes to produce cyclic ADP-ribose (cADPR) from ?-NAD+. This signal cascade is analogous to the previously established transduction pathways from bradykinin receptors to phospholipase C? and ?-adrenoceptors to adenylyl cyclase via G proteins. Upon receptor stimulation, the newlyformed cADPR may coordinately function to upregulate the release of Ca2+ from the type II ryanodine receptors as well as to facilitate Ca2+ influx through voltage-dependent Ca2+ channels. cADPR interacts with FK506, an immunosuppressant, at FKBP12.6, FK506-bindingprotein, and calcineurin, or ryanodine receptors. cADPR also functions through activating calcineurin released from Akinase anchoring protein (AKAP79). Thus, some Gq/11coupled receptors can control cADPR-dependent modulation in Ca2+ signaling.

:
Published Online: 2005-07-05
Published in Print: 2001-01-06

Copyright © 2001 by Walter de Gruyter GmbH & Co. KG

Articles in the same Issue

  1. To Our Authors, Readers and Subscribers
  2. Kinins 1925-2000
  3. The Expanded Human Kallikrein (KLK) Gene Family: Genomic Organisation, Tissue-Specific Expression and Potential Functions
  4. Novel Roles of Kallistatin, a Specific Tissue Kallikrein Inhibitor, in Vascular Remodeling
  5. Signal Transduction from Bradykinin, Angiotensin, Adrenergic and Muscarinic Receptors to Effector Enzymes, Including ADP-Ribosyl Cyclase
  6. Classification of Kinin Receptors
  7. Metabolism-Resistant Bradykinin Antagonists: Development and Applications
  8. Kinins, Receptors, Kininases and Inhibitors Where Did They Lead Us?
  9. Bradykinin Signalling to MAP Kinase: Cell-Specific Connections versus Principle Mitogenic Pathways
  10. Kinins and Epithelial Ion Transport in the Alimentary Tract
  11. Role of the Renal Kallikrein-Kinin System in the Development of Salt-Sensitive Hypertension
  12. Role of the Light Chain of High Molecular Weight Kininogen in Adhesion, Cell-Associated Proteolysis and Angiogenesis
  13. Activation of the Kinin-Forming Cascade on the Surface of Endothelial Cells
  14. Kallikrein and Kinin Receptor Expression in Inflammation and Cancer
  15. Altered Neutrophil Homeostasis in Kinin B1 Receptor-Deficient Mice
  16. Cystatins as Calpain Inhibitors: Engineered Chicken Cystatin- and Stefin B-Kininogen Domain 2 Hybrids Support a Cystatin-Like Mode of Interaction with the Catalytic Subunit of µ-Calpain
  17. Synthetic Peptides and Fluorogenic Substrates Related to the Reactive Site Sequence of Kunitz-Type Inhibitors Isolated from Bauhinia: Interaction with Human Plasma Kallikrein
  18. Identification and Characterization of an Aromatic Amino Acid Decarboxylase from the Filarial Nematode, Dirofilaria immitis
  19. Molecular Cloning and Pharmacological Characterization of the Canine B1 and B2 Bradykinin Receptors
  20. Ligand-Mediated Regulation of Kinin Receptors in the Rabbit
  21. Activation of Sphingosine Kinase by the Bradykinin B2 Receptor and Its Implication in Regulation of the ERK/MAP Kinase Pathway
Downloaded on 12.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/BC.2001.004/html
Scroll to top button